Alveolar Bone Loss Clinical Trial
Official title:
Influence of Soft Tissue Width and Abutment Height on Peri-implant Bone Resorption: a Clinical and Radiographic Multicenter Study
The purpose of this clinical and radiographic study will be to determine what influence on marginal bone loss has the thickness of soft tissues and the height of the prosthetic abutment and eventually determine which of the two factors is the most important.This research was designed as a multicentre cohort study. Two clinical centers will treat patients through the placement of a single dental implant. The implants will be prosthetically loaded about 4 months after placement and periapical radiographs will be acquired at each time-point.
The purpose of this clinical and radiographic study will be to determine what influence on
marginal bone loss has the thickness of soft tissues and the height of the prosthetic
abutment and eventually determine which of the two factors is the most important.This
research was designed as a multicentre cohort observational study. Two clinical centers will
treat patients through the placement of a single dental implant. The implants will be
prosthetically loaded about 4 months after placement and periapical radiographs will be
acquired at each time-point.
All patients will receive antibiotic prophylaxis with 2 g of amoxicillin one hour before
surgery. With the help of a dissector, a full thickness vestibular flap will be carefully
arranged and the vertical thickness of soft tissues will be measured with a probe marked
every 1.0 mm. If the vertical thickness of the soft tissue is 2 mm or less, the tissue will
be considered thin. If the thickness of the mucosa is greater than 2 mm, it will be
considered thick. After the measurement, the lingual flap will be elevated at full thickness,
and the site for site placement will be prepared. The implant bed will be at least 1.5 mm
from the adjacent tooth or teeth, and must be surrounded by at least 1 mm bone in both buccal
and lingual directions. A 3,75 mm diameter and internal hexagonal connection implant will be
placed at the level of the bone crest according to the manufacturer's recommendations.
Operators will be free to choose the most suitable system length (8, 10, 11.5 mm). All
implants will be submerged according to a traditional two-stage protocol. After insertion,
the flaps will be sutured without tension with interrupted sutures. Patients of both groups
will be instructed to disinfect the site by rinsing twice daily for one week for 1 minute
with 0.12% chlorhexidine. After 4 months of healing, the treated area will be reopened for
connecting the healing abutments with a crestal incision that will retain the keratinized
tissue; The same soft tissue measurements will be repeated as confirmation of what was done
during the first surgical implant insertion phase. The implants will be considered
osteointegrated successfully if they are clinically intact unless they show obvious
radiotransparency and patients will not report any pain. After this step, it will be possible
to divide the patients into 2 groups according to the thickness of the soft tissue: a group
with thick tissue (more than 2.0 mm); Slim tissue group (less than 2.0 mm). The prosthetic
framework will be bonded directly to prefabricated titanium abutment (1 or 3 mm). This will
result in the formation of 4 different subgroups: a group with thick tissue and high
prosthetic abutment; A group with thick tissue and low prosthetic stump; a group with thin
tissue and high prosthetic abutment; a group with thin tissue and low prosthetic abutment.
All the implants will be rehabilitated by the dentist with screwed restorations. After
prosthetic treatment, patients will receive oral hygiene instructions and will be monitored
through calls to ensure periodontal health throughout the study period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05470673 -
Autogenous Demineralized Dentin Graft Combined With Injectable PRF + Metronidazole Versus Autogenous Demineralized Dentin Graft Alone for Alveolar Ridge Preservation
|
N/A | |
Recruiting |
NCT02580721 -
The Influence of Mucosal Tissue Thickness on Soft and Hard Tissue Changes Around Implants
|
N/A | |
Completed |
NCT02515058 -
Ridge Preservation Following Tooth Extraction Using Two Mineralized Cancellous Bone Allografts
|
N/A | |
Enrolling by invitation |
NCT02209311 -
Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs
|
Phase 1/Phase 2 | |
Completed |
NCT02602223 -
Comparison of Amnion Chorion Membrane vs. Dense Polytetrafluoroethylene Membrane in Ridge Preservation Procedures
|
Phase 2 | |
Completed |
NCT02255149 -
A Feasibility Study for Growth Bone Vertically With Titanium Mesh and Allograft in Lower Posterior Jaw
|
N/A | |
Recruiting |
NCT06081296 -
Dimensional Changes in Alveolar Ridge Preservation
|
N/A | |
Recruiting |
NCT05674331 -
Clinical, Radiographical, Histological Evaluation and Blood Flow Analysis of Alveolar Ridge Preservation
|
N/A | |
Completed |
NCT03944811 -
Bone Height Gain Following Transcrestal Sinus Floor Elevation Using Piezoelectric Surgery Versus The Conventional Osteotome Technique
|
N/A | |
Completed |
NCT03045458 -
Associations of Alveolar Bone Loss and Interleukin-1β Levels in One and Two Stage Surgical Procedures
|
N/A | |
Completed |
NCT05595746 -
Radiological Bone Loss on Different Levels of Dental Implants
|
N/A | |
Completed |
NCT03357705 -
Effectiveness in Limiting the Need to Elevate the Maxillary Sinus
|
N/A | |
Recruiting |
NCT05311735 -
Mineralized and Partial Demineralized Dentin Graft Compared to FDBA
|
N/A | |
Completed |
NCT05494476 -
Stability of the Marginal Bone Around Subcrestal Implants
|
N/A | |
Not yet recruiting |
NCT05536479 -
Evaluation of Autogenous Stored Versus Autogenous Fresh Mineralized Dentin Graft for Alveolar Ridge Preservation
|
N/A | |
Active, not recruiting |
NCT02275767 -
Histological Evaluation of Healing Following Ridge Preservation Using a Combined Cortical/Cancellous Mineralized Freeze-Dried Bone Allograft
|
N/A | |
Active, not recruiting |
NCT02120053 -
Interest of Bone Substitute Material in Immediate Complete Denture
|
Phase 2/Phase 3 | |
Completed |
NCT01728844 -
GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery
|
N/A | |
Terminated |
NCT00991965 -
Localized Alveolar Ridge Augmentation With Dental Implant
|
N/A | |
Terminated |
NCT00991432 -
Localized Alveolar Ridge Augmentation With Space Maintenance Devices
|
N/A |